Natera NTRA
NASDAQ NTRA
$366.36 +21.02 (+6.08%)
As of: Sep 17, 2026 · 3:59 PM EDT

Natera (NTRA) Net Income towards Common Stockholders (2014 - 2026)

Natera's (NTRA) quarterly Net Income towards Common Stockholders came in at -$66.9 million in Q2 2026, up 33.71% on a YoY basis from -$50.1 million in Q2 2025, and up 21.36% quarter-over-quarter from -$85.1 million in Q1 2026.

Analysis

Natera (NTRA) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends

Natera (NTRA) has reported Net Income towards Common Stockholders for 13 consecutive years, with -$66.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 33.71% year-over-year to -$66.9 million; the trailing twelve-month figure through Jun 2026 stood at -$192.3 million (up 9.6% YoY), and the FY2025 full-year result was -$208.2 million, down 38.88% from the prior year.
  • Net Income towards Common Stockholders improved to -$66.9 million in Q2 2026 per NTRA's latest filing, from -$85.1 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $47.3 million in Q4 2025 and bottomed at -$145.2 million in Q2 2022.
  • Historically, Net Income towards Common Stockholders has averaged -$77.8 million across 5 years, with a median of -$86.3 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders plunged 197.71% in 2024, then jumped 458.85% in 2025.
  • Over 5 years, Net Income towards Common Stockholders stood at -$142.6 million in 2022, then surged by 109.46% to $13.5 million in 2023, then slumped by 197.71% to -$13.2 million in 2024, then surged by 458.85% to $47.3 million in 2025, then tumbled by 241.49% to -$66.9 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$66.9 million, -$85.1 million, and $47.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn -66.93 Mn
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 324.00 Mn
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 299.10 Mn
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn -120.14 Mn
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn 8.51 Mn
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -637,000.00
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 53.64 Mn
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn 8.05 Mn
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn -16.21 Mn
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn -381,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -66.93 Mn
Mar 31, 2026 -85.11 Mn
Dec 31, 2025 47.30 Mn
Sep 30, 2025 -87.54 Mn
Jun 30, 2025 -100.96 Mn
Mar 31, 2025 -66.96 Mn
Dec 31, 2024 -13.18 Mn
Sep 30, 2024 -31.59 Mn
Jun 30, 2024 -37.47 Mn
Mar 31, 2024 -67.60 Mn
Dec 31, 2023 13.49 Mn
Sep 30, 2023 -109.03 Mn
Jun 30, 2023 -110.80 Mn
Mar 31, 2023 -136.94 Mn
Dec 31, 2022 -142.57 Mn
Sep 30, 2022 -121.48 Mn
Jun 30, 2022 -145.15 Mn
Mar 31, 2022 -138.60 Mn
Dec 31, 2021 -140.56 Mn
Sep 30, 2021 -151.27 Mn